Joseph Monahan, Chief Scientific Officer at Aclaris Therapeutics, Inc. (ACRS), sold 60,000 shares at $16.28 ($977K) on 2022-04-18, disclosed to the SEC on 2022-04-20.
Open-market sale of $977k ACRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.28 | 30,000 | $488K | 50.0% |
| 2 | $16.28 | 30,000 | $488K | 50.0% |
| Total | $16.28 avg | 60,000 | $977K | 100% |
| Filing → |
| ACRS | SELL | 2023-06-22 | $123K | — | Filing → |
| ACRS | SELL | 2023-03-03 | $588K | — | Filing → |
| ACRS | SELL | 2023-02-17 | $65K | — | Filing → |